Advertisement

Immunology of Genital Papillomavirus Infections

  • S. Jablonska
  • S. Majewski
Conference paper

Abstract

Anogenital carcinomas and benign anogenital warts are associated with specific types of human papillomaviruses (HPVs). HPV 16, 18, 31 and 33 are the most common HPVs associated with anogenital carcinomas and/or with cervical dysplasia (Durst et al. 1983; Ikenberg et al. 1983; Boshart et al. 1984; Beaudenon et al. 1986; zur Hausen 1987; Howley 1987; zur Hausen and Schneider 1987). Also the newly characterized HPVs 35 (Lorincz et al. 1987), 45 (Nagashfar et al. 1987), 51 (Nuovo et al. 1988) and 52 (Shimoda et al. 1988) have been found to be associated with intraepithelial neoplasia and invasive carcinoma of the cervix. In contrast, HPV 6 and 11 are associated, in general, with benign anogenital lesions, i.e. with condylomata acuminata and lowgrade cervical intraepithelial neoplasia (de Villiers et al. 1981; Gissmann et al. 1982, 1983). Some other newly characterized HPVs, 42 (Beaudenon et al. 1987) and 44 (Lorincz et al. 1989), can also be regarded as a low risk for the development of genital cancer. However, HPV 6 subtypes have been detected repeatedly in locally destructive anogenital verrucous carcinomas (Okagaki et al. 1984; Lehn et al. 1984; Boshart and zur Hausen 1986; Rando et al. 1986; Guillet et al. 1988; Kasher and Roman 1988). HPV 16 is also associated with bowenoid papulosis (Durst et al. 1983; Gross et al. 1985, 1986; Obalek et al. 1985, 1986), with histological features of Bowen’s atypia, usually regressing after several months or years of duration. However, in some cases of bowenoid papulosis malignant transformation may occur (Lloyd 1970; Bergeron et al. 1987).

Keywords

Cervical Intraepithelial Neoplasia Genital Wart Verrucous Carcinoma Cervical Neoplasia Condyloma Acuminata 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abcarian H, Sharon N (1977) The effectiveness of immunotherapy in the treatment of anal condyloma acuminatum. J Surg Res 22: 231–236PubMedCrossRefGoogle Scholar
  2. Baird PJ (1983) Serological evidence for the association of papillomavirus and cervical neoplasia. Lancet 2: 17–18PubMedCrossRefGoogle Scholar
  3. Bankhurst AD (1982) The modulation of human natural killer cell activity by prostaglandins. J Clin Lab Immunol 7: 85–91PubMedGoogle Scholar
  4. Beaudenon S, Kremsdorf D, Croissant O, Jablonska S, Wain-Hobson S, Orth G (1986) A novel type of human papillomavirus associated with genital neoplasias. Nature 321: 246–249PubMedCrossRefGoogle Scholar
  5. Beaudenon S, Kremsdorf D, Obalek S, Jablonska S, Pehau-Arnaudet M, Croissant O, Orth G (1987) Plurality of genital human papillomaviruses: characterization of two new types with distinct biological properties. Virology 161: 374–384PubMedCrossRefGoogle Scholar
  6. Berg JW, Lampe JG (1981) High-risk factors in gynecologic cancer. Cancer 48: 429–441PubMedCrossRefGoogle Scholar
  7. Bergeron C, Naghashfar Z, Canaan C, Shah K, Fu YS, Ferenczy A (1987) Human papillomavirus type 16 in intraepithelial neoplasia (bowenoid papulosis) and coexistent invasive carcinoma of the vulva. J Gynecol Pathol 6: 1–11CrossRefGoogle Scholar
  8. Blohme I, Bryuger H (1985) Malignant disease in renal transplant patients. Transplantation 39: 23–25PubMedGoogle Scholar
  9. Boshart M, zur Hausen H (1986) Human papillomaviruses in Buschke-Loewenstein tumors: physical state of the DNA and identification of a tandem duplication in the noncoding region of a human papillomavirus 6 subtype. J Virol 56: 963–966Google Scholar
  10. Boshart M, Gissmann L, Ikenberg H, Kleinheintz A, Scheurlen W, zur Hausen H (1984) A new type of papillomavirus DNA, its presence in genital cancer biopsies and cell lines from cervical cancer. EMBO J 3: 1151–1157PubMedGoogle Scholar
  11. Choi KS, Sauder DN (1986) The role of Langerhans cells and keratinocytes in epidermal immunity. J Leukoc Biol 39: 349–358Google Scholar
  12. Cubie HA, Norval M (1988) Humoral and cellular immunity to papillomavirus in patients with cervical dysplasia. J Med Virol 24: 85–95PubMedCrossRefGoogle Scholar
  13. De Villiers EM, Gissmann L, zur Hausen H (1981) Molecular cloning of viral DNA from human genital warts. J Virol 40: 932–935PubMedGoogle Scholar
  14. Dunn J, Wenstein L, Orogemuller W, Mainke W (1981) Immunological detection of condylomata acuminata-specific antigens. Obstet Gynecol 57: 351–356PubMedGoogle Scholar
  15. Durst M, Gissmann L, Ikenberg M, zur Hausen H (1983) A papillomavirus DNA from cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 80: 3812–3815PubMedCrossRefGoogle Scholar
  16. Evans CA, Thomsen JJ (1969) Antitumor immunity in the Shope papilloma-carcinoma complex. IV. Search for a transmissible factor increasing the frequency of tumor regression. JNCI 42: 477–484Google Scholar
  17. Galloway DA, Jenison SA, Valentine J, Koutsky L, Holmes K, Langenberg A, Corey L, Sherman K, Daling J (1988) Prevalence of antibody to HPV6 and HPV16 in various populations. In: 7th International Papillomavirus Workshop, Antipolis, p 230Google Scholar
  18. Gissmann L, de Villiers E, zur Hausen H (1982) Analysis of human genital warts (condylomata acuminata) and other genital tumors for human papillomavirus type DNA. Int J Cancer 29: 143–146Google Scholar
  19. Gissmann L, Wolnik L, Ikenberg H, Koldovsky U, Schnurch HG, zur Hausen H (1983) Human papillomavirus type 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci USA 80: 560–563PubMedCrossRefGoogle Scholar
  20. Goto M, Tanimoto K, Horiuchi Y (1980) Natural cell-mediated cytotoxicity (NCMC) in systemic lupus erythematosus: suppression of NCMC by anti-lymphocyte antibody. Arthritis Rheum 23: 1274–1281PubMedCrossRefGoogle Scholar
  21. Gross G, Hagedorn M, Ikenberg H, Rufli T, Grosshans E, Gissmann L (1985) Bowenoid papulosis. Presence of human papillomavirus (HPV) structural antigens and of HPV16-related DNA sequences. Arch Dermatol 121: 858–863PubMedCrossRefGoogle Scholar
  22. Gross G, Ikenberg H, de Villiers EM, Schneider A, Wagner D, Gissmann L (1986) Bowenoid papulosis: a venereally transmissible disease as reservoir for HPV16. In: Peto R, zur Hausen H (eds) Viral etiology of cervical cancer. Cold Spring Harbor Laboratories, New York, pp 149–165 (Bandbury report, vol 21 )Google Scholar
  23. Guillet G, Foucher JM, Le Roy JP (1988) Degenerescence spino-cellulaire d’ une tumeur de Buschke-Loewenstein a HPV6. Ann Dermatol Venereol 115: 339–343PubMedGoogle Scholar
  24. Haranaka H, Satomi N, Sakurai A, Haranaka R (1987) Antitumor effects of tumor necrosis factor: cytotoxic or necrotizing activity and its mechanism. Ciba Found Symp 131: 140–153PubMedGoogle Scholar
  25. Herberman RB (ed) (1980) Natural cell-mediated immunity against tumors. Academic Press, New YorkGoogle Scholar
  26. Herberman RB (ed) (1982) NK cells and other effector cells. Academic Press, New York Holmes EGoogle Scholar
  27. Sibbitt WL Jr, Bankhurst AD (1986) Serum factors which suppress natural cytotoxicity in cancer patients. Int Arch Allergy Appl Immunol 80: 39–43PubMedCrossRefGoogle Scholar
  28. Howley PM (1987) The role of papillomaviruses in human cancer. In: De Vita VT, Hellman S, Rosenberg SA (eds) Important advances in oncology. Lippincott, Philadelphia, pp 55–73Google Scholar
  29. Hsu CCS (1974) Peripheral blood lymphocyte responses to phytohemagglutin and pokeweed mitogen during pregnancy. Proc Soc Exp Biol Med 146: 771–775PubMedGoogle Scholar
  30. Ikenberg H, Gissmann L, Gross G, Grussendorf-Cohen EJ, zur Hausen H (1983) Human papillomavirus type-16-related DNA in genital Bowen’s disease and in bowenoid papulosis. Int J Cancer 15: 563–565CrossRefGoogle Scholar
  31. Jablonska S, Orth G (1983) Human papillomaviruses. In: Rook A, Maibach H (eds) Recent advances in dermatology, vol 6. Churchill Livingstone, London, pp 1–36Google Scholar
  32. Jablonska S, Orth G, Jarzabek-Chorzelska M, Rzesa G, Obalek S, Glinski W, Favre M, Croissant O (1979) Epidermodysplasia verruciformis versus disseminated verrucae. J Invest Dermatol 72: 114–119PubMedCrossRefGoogle Scholar
  33. Jablonska S, Orth G, Lutzner MA (1982) Immunopathology of papillomavirus-induced tumors in different tissues. Springer Semin Immunopathol 5: 33–62PubMedCrossRefGoogle Scholar
  34. Jablonska S, Obalek S, Orth G, Breitburd F, Croissant O (1988) Tumeur geante de Buschke-Lowenstein a HPV6 avec metastases dans la paroi abdominale. Ann Dermatol V enereo1115: 1201–1202Google Scholar
  35. Janovsky NA, Barchet S (1966) Multicentric Bowen’s disease of the vulva. Obstet Gynecol 28: 170–174Google Scholar
  36. Jarret WFH (1985) Bovine papillomaviruses. In: Warts — human papillomaviruses. Clin Dermatol 3: 8–19Google Scholar
  37. Jarret WFH, Campo MS, Moar MH, McNeil PE, Laird HM, O’Neil BW, Murphy J (1980) Papillomaviruses in benign and malignant tumors of cattle. In: Viruses in naturally occurring cancers. 7th Conference on Cell Proliferation. Cold Spring Harbor, Laboratories, New YorkGoogle Scholar
  38. Jenison SA, Yu XP, Valentine J, Galloway DA (1989) Human antibodies react with an epitope of human papillomavirus type 6B L1 open reading frame which is distinct from the type-common epitope. J Virol 62: 809–818Google Scholar
  39. Jenson AB, Kurman RJ, Lancaster WD (1987) Tissue effects and host response to human papillomavirus infection. Obstet Gynecol Clin North Am 14: 397–406PubMedGoogle Scholar
  40. Jochmus-Kudielka I, Schneider A, Braun R, Kimmig R, Koldovsky U, Schneweis KE, Seedorf K, Gissmann L (1989) Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst 81: 1698–1704PubMedCrossRefGoogle Scholar
  41. Kasher MS, Roman A (1988) Characterization of human papillomavirus type 6B DNA isolated from an invasive squamous carcinoma of the vulva. Virology 165: 225–233PubMedCrossRefGoogle Scholar
  42. Katz RL, Veanattukalathil S, Weiss (1987) Human papillomavirus infection and neoplasia of the cervix and anogenital region in women with Hodgkin’s disease. Acta Cytol 31: 845–854Google Scholar
  43. Katz SJ (1985) The skin as an immunologic organ. J Am Acad Dermato113: 530–536Google Scholar
  44. Kreider JW (1980) Neoplastic progression of the Shope rabbit papilloma. In: Viruses in naturally occurring cancers. 7th Conference on Cell Proliferation. Cold Spring Harbor Laboratories, New York, pp 283–300Google Scholar
  45. Kreider JW, Bartlett GL (1981) The Shope papilloma-carcinoma complex of rabbits. A model system of neoplastic progression and spontaneous regression. In: Klein G, Weinhouse S (eds) Advances in cancer research, vol 35. Academic, New York, pp 81–110Google Scholar
  46. Kreider JW, Bartlett GL (1985) Shope rabbit papilloma-carcinoma complex: a model system of human papillomavirus infections. Clin Dermatol 3: 20–26PubMedCrossRefGoogle Scholar
  47. Kupper TS (1988) Interleukin-1 and other human keratinocyte cytokines: molecular and functional characterization. Adv Dermatol 3: 293–308PubMedGoogle Scholar
  48. Lanier LL, Le AH, Phillips JH, Warner NL, Babcock GF (1983) Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NKP-15) antigens. J Immunol 131: 1789–1795PubMedGoogle Scholar
  49. Lehn H, Ernst TM, Sauer G (1984) Transcription of episomal papillomavirus DNA in human condylomata acuminata and Buschke-Loewenstein tumors. J Gen Virol 65: 2003–2010PubMedCrossRefGoogle Scholar
  50. Li CC, Shah KV, Seth A, Gilden RV (1987) Identification of the human papillomavirus type 6B L1 open reading frame protein in condylomas and corresponding antibodies in human sera. J Virol 61: 2684–2690PubMedGoogle Scholar
  51. Limatibul S, Shore A, Dosch HM, Geleand EW (1978) Theophylline modulation of E-rosette formation: an indicator of T-cell maturation. Clin Exp Immunol 33: 503–513PubMedGoogle Scholar
  52. Lloyd KM (1970) Multicentric pigmented Bowen’s disease of the groin. Arch Dermatol 101: 48–51PubMedCrossRefGoogle Scholar
  53. Lorincz AT, Quinn AP, Lancaster WD, Temple GF (1987) A new type of papillomavirus associated with cancer of the uterine cervix. Virology 159: 187–190PubMedCrossRefGoogle Scholar
  54. Lorincz AT, Quinn AP, Goldsborough MD, Schmidt BJ, Temple GF (1989) Cloning and partial DNA sequencing of two new papillomavirus types associated with condylomas and low-grade cervical neoplasia. J Viro! 63: 2829–2834Google Scholar
  55. Luger TA, Kock A, Danner M (1985) Production of distinct cytokines by epidermal cells. Br J Dermato1113 [Supp128]: 145–156Google Scholar
  56. Luger TA, Uchida A, Kock A, Colot M, Micksche M (1985) Human epidermal cell and squamous carcinoma cells synthetize a cytokine that augments natural killer cell activity. J Immunol 134: 2477–2483PubMedGoogle Scholar
  57. Majewski S, Skopinska-Rozewska E, Jablonska S, Wasik M, Misiewicz J, Orth G (1986) Partial defects of cell-mediated immunity in patients with epidermodysplasia verruciformis. J Am Acad Dermatol 15: 966–973PubMedCrossRefGoogle Scholar
  58. Majewski S, Malejczyk J, Jablonska S, Misiewicz J, Rudnicka L, Obalek S, Orth G (1990) Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis. J Am Acad Dermatol 22: 423–427PubMedCrossRefGoogle Scholar
  59. Malejczyk J, Majewski S, Jablonska S, Orth G (1987) Natural cell-mediated cytotoxicity in patients with anogenital lesions induced by potentially oncogenic human papillomaviruses. In: Steinberg BM, Brandsma JL, Taichman LB (eds) Cancer cells, vol 5, papillomaviruses. Cold Spring Harbor Laboratories, New York, pp 381–385Google Scholar
  60. Malejczyk J, Majewski S, Jablonska S, Rogozinski TT, Orth G (1989) Abrogated NKcell lysis of human papillomavirus (HPV)-16-bearing keratinocytes in patients with precancerous and cancerous HPV-induced anogenital lesions. Int J Cancer 43: 209–214PubMedCrossRefGoogle Scholar
  61. Malison MD, Morris R, Jones LW (1982) Autogenous vaccine therapy for condyloma acuminatum. A double-blind controlled study. Br J Vener Dis 58–62Google Scholar
  62. Morin C, Braun L, Casas-Cordero M, Shah KV, Roy M, Fortier M, Meisels A (1981) Confirmation of the papillomavirus etiology of condylomatous cervix lesions by peroxidase-antiperoxidase technique. JCNI 66: 831–835Google Scholar
  63. Morris HHB, Gatter KC, Sykes G, Casemore V, Mason DY (1983) Langerhans cells in human cervical epithelium: effects of wart virus infection and intraepithelial neoplasia. Br J Obstet Gynaecol 90: 412–420PubMedCrossRefGoogle Scholar
  64. Naghashfar ZS, Rosenshein NB, Lorincz AT, Buscema J, Shah KV (1987) Characterization of human papillomavirus type 45, a new type 18-related virus of the genital tract. J Gen Virol 68: 3073–3079PubMedCrossRefGoogle Scholar
  65. Nouvo GJ, Crum CP, de Villiers EM, Levine RU, Silverstein SJ (1988) Isolation of a novel human papillomavirus (type 51) from a cervical condyloma. J Virol 62: 1452–1455Google Scholar
  66. Obalek S, Glinski W, Haftek M, Orth G, Jablonska S (1980) Comparative studies on cell-mediated immunity in patients with different warts. Dermatologica 161: 73–83PubMedCrossRefGoogle Scholar
  67. Obalek S, Jablonska S, Orth G (1985) HPV-associated intraepithelial neoplasia of the external genitalia. In: Warts — human papillomaviruses. Clin Dermatol 3: 104–113PubMedCrossRefGoogle Scholar
  68. Obalek S, Jablonska S, Beaudenon MB, Walczak L, Orth G (1986) Bowenoid papulosis of the male and female genitalia: risk of cervical neoplasia. J Am Acad Dermatol 14: 433–444PubMedCrossRefGoogle Scholar
  69. Okagaki T (1986) Human genital papilloma infections: an evaluation of immunologic competence in the genital neoplasia-papilloma syndrome. Am J Obstet Gynecol 155: 784–789PubMedGoogle Scholar
  70. Okagaki T, Clark BA, Zachow KR, Twiggs LB, Ostrow RS, Pass F, Faras AJ (1984) Presence of human papillomavirus in verrucous carcinoma ( Ackerman) of the vagina. Arch Pathol Lab Med 108: 567–570PubMedGoogle Scholar
  71. Ortaldo JR, Herberman RB (1984) Heterogeneity of natural killer cells. Ann Rev Immunol 2: 359–394CrossRefGoogle Scholar
  72. Pelissier CI, Yaneva M, Joubert E (1981) Cancers genitaux et lesions precancereuses chez les femmes transplantées rénales. A propos de l ’ étude de 90 femmes greffées.Gynecologie 32: 359–365Google Scholar
  73. Penn I (1986) Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer 58: 611–616PubMedCrossRefGoogle Scholar
  74. Porecco R, Penn I, Droegmneller W, Greer B, Makowski E (1975) Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet Gynecol 45: 359–364Google Scholar
  75. Portolani M, Mantovani G, Pietrosemoli P, Cermelli C, Bosetli F (1987) Antibodies to papillomavirus genus antigens in women with genital warts. Microbiologica 10: 271–279PubMedGoogle Scholar
  76. Pyrhonen S, Jablonska S, Obalek S, Kuismanen E (1980) Immune reactions in epidermodysplasia verruciformis. Br J Dermatol 102: 247–254PubMedCrossRefGoogle Scholar
  77. Rando RF, Groff DE, Chirikjian JG, Lancaster WD (1986) Isolation and characterization of a novel human papillomavirus type 6 DNA from an invasive vulvar carcinoma. J Virol 57: 353–356PubMedGoogle Scholar
  78. Rogozinski T, Klein MK, Bailey D, Schachter RK (1986) Cell-mediated immunity in bowenoid papulosis (bp), multicentric pigmented Bowen’s disease (MPBD). Presented at the International Congress of Clinical Immunology, Toronto, 1986Google Scholar
  79. Roth JA (1983) Tumor-induced immunosuppression. Surg Gynecol Obstet 156: 233–240PubMedGoogle Scholar
  80. Rudlinger R, Grob R, Buchmann P, Christen D, Steiner R (1988) Anogenital warts of the condyloma acuminatum type in HIV-positive patients. Dermatologica 176: 277–28PubMedCrossRefGoogle Scholar
  81. Schneider V, Kay S, Lee HM (1983) Immunosuppression as a high-risk factor in the development of condyloma acuminatum and squamous neoplasia of the cervix. Acta Cytol 27: 220–224PubMedGoogle Scholar
  82. Schneider-Maunoury S, Croissant O, Orth G (1987) Integration of human papillomavirus type 16 DNA sequences: a possible early event in the progression of genital tumors. J Virol 61: 3295–3298PubMedGoogle Scholar
  83. Seski JC, Reinhalter ER, Silva J (1978) Abnormalities of lymphocyte transformations in women with condylomata acuminata. Obstet Gynecol 51: 188–192PubMedGoogle Scholar
  84. Seto A, Notake K, Kawanishi M, Ito Y (1977) Development and regression of Shope papilloma induced in newborn domestic rabbits. Proc Soc Exp Biol Med 156: 64–67PubMedGoogle Scholar
  85. Shimoda K, Lorincz AT, Temple GF, Lancaster WD (1988) Human papillomavirus type 52: a new virus associated with cervical neoplasia. J Gen Viro 69: 2925–2928CrossRefGoogle Scholar
  86. Shore A, Dosch MM, Gelfand EW (1978) Induction and separation of antigen-dependent T-helper and T-suppressor cells in man. Nature 247: 586–587CrossRefGoogle Scholar
  87. Sillman FH, Sedlis A (1987) Anogenital papillomavirus infection and neoplasia in im-munodeficient women. Obstet Gynecol Clin North Am 14: 537–558PubMedGoogle Scholar
  88. Sillman FH, Stanek A, Sedlis A, Rosenthal J, Lanks KW, Buchhagen D, Nicastri A, Boyce J (1984) The relationship between human papillomavirus and lower genital intraepithelial neoplasia in immunosuppressed women. Am J Obstet Gynecol 150: 300–308PubMedGoogle Scholar
  89. Silverman SL, Cathcart ES (1980) Natural killing in systemic lupus erythematosus: inhibitory effects of serum. Clin Immunol Immunopathol 17: 219–226PubMedCrossRefGoogle Scholar
  90. Skinner MS, Sternberg WH, Ichinose H, Collons J (1973) Spontaneous regression of bowenoid atypia of the vulva. Obstet Gynecol 42: 40–46PubMedGoogle Scholar
  91. Skopinska-Rozewska E, Majewski S, Blaszczyk M, Wlodarska B, Jablonska S (1988) Theophylline-resistant and theophylline-sensitive “active” and “total” E-rosetteforming lymphocytes in patients with systemic scleroderma. J Invest Dermatol 90: 851–856PubMedCrossRefGoogle Scholar
  92. Strang G, Hickling JK, Mc Indoe GAJ, Howland K, Wilkinson D, Ikeda H, Rothbard JB (1990) Human T cell responses to human papillomavirus type 16 L and E6 synthetic peptides. Identification of T cell determinants, HLA-DR restriction and virus type specificity. J Gen Virol 71: 423–431PubMedCrossRefGoogle Scholar
  93. Streilein JW (1983) Skin-associated lymphoid tissue (SALT): origins and functions. J Invest Dermatol 80 [Suppl]: 12–16CrossRefGoogle Scholar
  94. Syrjänen KJ (1984) Current concepts on human papillomavirus (HPV) infections in the genital tract and their relationship to intraepithelial neoplasia and squamous cell carcinoma. Obstet Gynecol Sury 39: 252–262CrossRefGoogle Scholar
  95. Tay SK, Jenkins D, Maddox P, Hogg N, Singer A (1987) Tissue macrophage response in human papillomavirus infection and cervical intraepithelial neoplasia. Br J Ob-stet Gynaecol 94: 1094–1097CrossRefGoogle Scholar
  96. Tyring SK, Cauda R, Grossi CE, Tilden AB, Haych KD, Sams WM, Baron S, Whitley RJ (1986) Peripheral blood mononuclear cells from patients with condylomata acuminata exhibit decreased interleukin-2 and interferon-gamma production and depressed natural killer activity. J Invest Dermatol 87: 172Google Scholar
  97. Van de Linde AW, Streefkerk M, Schuurman HJ, Te Velde ER, Kater L (1983) Divergence between the occurrence of antibody and cellular immune reactivity to cervical carcinoma cell lines in preinvasive and macroinvasive stages of cervical carcinoma. Br J Cancer 47: 147–153CrossRefGoogle Scholar
  98. Vayrynen M, Syrjänen K, Mantyjarvi R, Casten O, Saarikoski S (1985) Immunophenotypes of lymphocytes in prospectively followed up human papillomavirus lesions of the cervix. Genitourin Med 61: 190–196PubMedGoogle Scholar
  99. von Krogh G (1983) Condylomata acuminata 1983: an up-dated review. Semin Dermatopatho 12: 109–129Google Scholar
  100. Wolff K, Stingl G (1983) The Langerhans cell. J Invest Dermatol 80 [Suppl]: 17–21CrossRefGoogle Scholar
  101. zur Hausen H (1986) Intrâcellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expres-sion. Lancet 2: 489–491PubMedCrossRefGoogle Scholar
  102. zur Hausen H (1987) Papillomaviruses in human cancer. Appl Pathol 5: 19–24PubMedGoogle Scholar
  103. zur Hausen H, Schneider A (1987) The role of papillomavirus in human anogenital cancer. In: Salzman NP, Howley PM (eds) The papillomaviruses. Plenum, New York, pp 245–263 (The papovaviridae, vol 2 )Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • S. Jablonska
  • S. Majewski

There are no affiliations available

Personalised recommendations